1. Home
  2. DLPN vs AYTU Comparison

DLPN vs AYTU Comparison

Compare DLPN & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

HOLD

Current Price

$1.65

Market Cap

21.8M

ML Signal

HOLD

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

HOLD

Current Price

$2.11

Market Cap

20.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLPN
AYTU
Founded
1996
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.8M
20.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DLPN
AYTU
Price
$1.65
$2.11
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.17
AVG Volume (30 Days)
34.5K
56.3K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$53,371,115.00
$63,696,000.00
Revenue This Year
$9.05
N/A
Revenue Next Year
$15.42
$29.12
P/E Ratio
N/A
N/A
Revenue Growth
3.86
N/A
52 Week Low
$0.75
$0.95
52 Week High
$1.88
$2.82

Technical Indicators

Market Signals
Indicator
DLPN
AYTU
Relative Strength Index (RSI) 48.38 46.36
Support Level $1.60 $1.91
Resistance Level $1.84 $2.18
Average True Range (ATR) 0.12 0.13
MACD -0.02 0.01
Stochastic Oscillator 31.58 39.24

Price Performance

Historical Comparison
DLPN
AYTU

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: